tiprankstipranks
Standard BioTools (LAB)
NASDAQ:LAB
US Market

Standard BioTools (LAB) Income Statement

Compare
445 Followers

Standard BioTools Income Statement

Last quarter (Q3 2024), Standard BioTools's total revenue was $44.97M, an increase of 77.27% from the same quarter last year. In Q3, Standard BioTools's net income was $-26.94M. See Standard BioTools’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 106.34M$ 97.95M$ 130.58M$ 138.14M$ 117.24M
Gross Profit
$ 50.45M$ 37.05M$ 69.37M$ 83.33M$ 64.28M
Operating Expenses
$ 127.05M$ 153.26M$ 136.83M$ 134.36M$ 116.12M
Depreciation and Amortization
$ 15.18M$ 15.03M$ 16.07M$ 17.94M$ 15.80M
EBITDA
$ -54.46M$ -173.57M$ -43.77M$ -34.60M$ -46.62M
Operating Income
$ -76.60M$ -116.20M$ -67.46M$ -51.04M$ -51.84M
Other Income/Expenses
$ 2.40M$ -76.72M$ 3.80M$ -3.06M$ -14.87M
Pretax Income
$ -74.20M$ -192.93M$ -63.66M$ -54.10M$ -66.70M
Net Income
$ -74.66M$ -190.10M$ -59.24M$ -53.02M$ -64.79M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -0.94$ -2.43$ -0.78$ -0.74$ -0.97
Diluted EPS
$ -0.94$ -2.43$ -0.78$ -0.74$ -0.97
Weighted Average Shares Outstanding
79.16M 78.31M 75.79M 72.04M 66.78M
Weighted Average Shares Outstanding (Diluted)
79.16M 78.31M 75.79M 72.04M 66.78M
Currency in USD

Standard BioTools Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis